NIH-funded study identifies gene variant as potential drug target
Defying the odds, an individual at high risk for early-onset Alzheimer’s disease remained dementia-free for many years beyond what was anticipated. A study funded in part by the National Institute on Aging (NIA), part of the National Institutes of Health, led researchers to suggest that a gene variant may be the key, perhaps providing a new direction toward developing a treatment.
The research focused on the case of a woman who carried a gene mutation known to cause early-onset Alzheimer’s. However, she did not develop signs of the disease until her seventies, nearly three decades after her expected age of onset. The researchers suspect that she may have been protected because in addition to the gene mutation causing early-onset Alzheimer’s in her family, she also had two copies of the APOE3 Christchurch (APOE3ch) gene variant. Findings of this case study as published in Nature Medicine suggest that two copies of the APOE3ch variant, named after Christchurch, New Zealand where it was first identified, may protect against Alzheimer’s.
“Sometimes close analysis of a single case can lead to discovery that could have broad implications for the field,” said NIA Director Richard J. Hodes, M.D. “We are encouraged that as part of our wide array of studies, this research in the unique genetic makeup of an exceptional individual can reveal helpful information.”
Early-onset Alzheimer’s disease is rare, representing less than 10% of all people who have Alzheimer’s. It typically occurs between a person’s 30s to mid-60s. Risk for both early- and late-onset Alzheimer’s disease is affected by genetic factors.
For the study, researchers led by investigators at Massachusetts General Hospital, Boston, in collaboration with the University of Antioquia, Medellin, Colombia, Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, and Banner Alzheimer’s Institute, Phoenix, looked at genetic data from a Colombian family with more than 6,000 living members. Family members who carry a rare gene mutation called Presenilin 1 (PSEN1) E280A, have a 99.9% risk of developing early-onset Alzheimer’s disease.
The researchers confirmed that the woman in this case carried the PSEN1 E280A mutation, which caused early-onset Alzheimer’s in her other family members. However, she also had two copies of the APOE3ch gene variant, while no other affected family member carried two copies of this variant. Affected family members develop Alzheimer’s in their 40s, but she remained disease free until her 70s. Imaging tests showed that the woman had only minor neurodegeneration. She did have large amounts of amyloid protein deposits, a hallmark of Alzheimer’s disease, in her brain. But the amount of tau tangles, another hallmark of the disease, and the one more correlated with how thinking and memory are affected, was relatively low.
Experiments as part of the study showed that the APOE3ch variant may reduce the ability of APOE to bind to certain sugars called heparan sulphate proteoglycans (HSPG). APOE binding to HSPG has been implicated as one mechanism that may contribute to the amyloid and tau protein deposits that destroy the brain. The research suggests that a drug or gene therapy that could reduce APOE and HSPG binding has the potential to be a new way to treat or prevent Alzheimer’s disease.
The Latest on: Alzheimer’s
[google_news title=”” keyword=”Alzheimer’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s
- Preparing for a new chapter: disease modifying treatments for early Alzheimer’s diseaseon December 7, 2023 at 12:41 am
NHS England has been closely monitoring a pipeline of new disease modifying treatments (DMTs) in development for mild cognitive impairment associated with early or mild Alzheimer’s disease. One of ...
- Quick test shows risk of everything from Alzheimer's to heart diseaseon December 6, 2023 at 10:55 pm
Researchers say the blood test could be used to find people at risk of organ failure and diseases of the immune system ...
- Scientists Have Discovered New Pathways of Alzheimer’s Diseaseon December 6, 2023 at 4:13 pm
Dementia, encompassing conditions like Alzheimer's disease, impacts approximately 1.8 million individuals in Germany. The precise origins of this disease are still not fully understood, though it's ...
- Choir of Alzheimer's patients uses the power of music to spark memoryon December 6, 2023 at 2:49 pm
At the heart of music is the shared experience. Emily Pearl and her mother, Kaye, have been part of the Giving Voice Chorus in St. Paul since 2018. The vocalists making the three- and four-part ...
- Choir forges connection of music among Alzheimer’s patientson December 6, 2023 at 2:41 pm
The Twin Cities-based Giving Voice chorus is a place where people with dementia are recognized for what they can do, including learning new music, making new memories and remembering old songs.
- Scientists Discover Ways To Reduce Symptoms in Alzheimer's Diseaseon December 6, 2023 at 11:00 am
Two new studies reveal that electrical stimulation of the brain and light therapy treatment might help patients with Alzheimer's.
- Alzheimer’s: Jack Draper raising awareness of disease after 'devastating' effect on his grandmotheron December 6, 2023 at 8:33 am
Briton Jack Draper is raising awareness of Alzheimer’s disease after describing the "devastating" effect the condition has had on his grandmother.
- Annual Alzheimer’s and Dementia Report given to Arkansas lawmakers, requests state match federal grant for caregiverson December 6, 2023 at 6:36 am
Arkansas legislators got a firsthand look at the 2023 annual report from the Alzheimer’s and Dementia Advisory Council Tuesday.
- What to eat at breakfast, lunch and dinner to slash your risk of Alzheimer’s revealedon December 6, 2023 at 6:02 am
SCIENTISTS have revealed what you should eat for breakfast, lunch and dinner to slash your risk of Alzheimer’s disease. Sticking to a Mediterranean or traditional Chinese, Japanese or Indian diet ...
- Fasting could reduce signs of Alzheimer’s disease, studies suggest: ‘Profound effects’on December 6, 2023 at 3:26 am
Participating in intermittent (time-restricted) fasting could lead to a reduced risk of cognitive deterioration, recent studies suggest. The researchers shared findings with Fox News Digital.
via Bing News